No retraction, correction or concern found when last checked on Oct 17, 2026.

Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut

Martin F. Laursen, Mikiyasu Sakanaka, Nicole von Burg and 17 more

Nature Microbiology · 2021 · CC BY

Abstract

Breastfeeding profoundly shapes the infant gut microbiota, which is critical for early life immune development, and the gut microbiota can impact host physiology in various ways, such as through the production of metabolites. However, few breastmilk-dependent microbial metabolites mediating host–microbiota interactions are currently known. Here, we demonstrate that breastmilk-promoted Bifidobacterium species convert aromatic amino acids (tryptophan, phenylalanine and tyrosine) into their respective aromatic lactic acids (indolelactic acid, phenyllactic acid and 4-hydroxyphenyllactic acid) via a previously unrecognized aromatic lactate dehydrogenase (ALDH). The ability of Bifidobacterium species to convert aromatic amino acids to their lactic acid derivatives was confirmed using monocolonized mice. Longitudinal profiling of the faecal microbiota composition and metabolome of Danish infants ( n = 25), from birth until 6 months of age, showed that faecal concentrations of aromatic lactic acids are correlated positively with the abundance of human milk oligosaccharide-degrading Bifidobacterium species containing the ALDH, including Bifidobacterium longum , B. breve and B. bifidum . We further demonstrate that faecal concentrations of Bifidobacterium -derived indolelactic acid are associated with the capacity of these samples to activate in vitro the aryl hydrocarbon receptor (AhR), a receptor important for controlling intestinal homoeostasis and immune responses. Finally, we show that indolelactic acid modulates ex vivo immune responses of human CD4 + T cells and monocytes in a dose-dependent manner by acting as an agonist of both the AhR and hydroxycarboxylic acid receptor 3 (HCA 3 ). Our findings reveal that breastmilk-promoted Bifidobacterium species produce aromatic lactic acids in the gut of infants and suggest that these microbial metabolites may impact immune function in early life.

References 111

1.
Victora CG, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387:475-490.
Not in our library10.1016/s0140-6736(15)01024-7
2.
Horta BL, Loret de Mola C, Victora CG. Long-term consequences of breastfeeding on cholesterol, obesity, systolic blood pressure and type 2 diabetes: a systematic review and meta-analysis. Acta Paediatr. 2015;104:30-37.
Not in our library10.1111/apa.13133
3.
Oddy WH. Breastfeeding, childhood asthma, and allergic disease. Ann. Nutr. Metab. 2017;70:26-36.
Not in our library10.1159/000457920
4.
Infant Gut Microbiota Development Is Driven by Transition to Family Foods Independent of Maternal Obesity · 2016
No notice
5.
Bäckhed F, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17:690-703.
Not in our library10.1016/j.chom.2015.04.004
6.
Temporal development of the gut microbiome in early childhood from the TEDDY study · 2018
No notice
7.
Bode L. The functional biology of human milk oligosaccharides. Early Hum. Dev. 2015;91:619-622.
Not in our library10.1016/j.earlhumdev.2015.09.001
8.
Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352:539-544.
Not in our library10.1126/science.aad9378
9.
Maturation of the gut microbiome and risk of asthma in childhood · 2018
Corrected
10.
Fujimura KE, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat. Med. 2016;22:1187-1191.
Not in our library10.1038/nm.4176
11.
Khosravi A, Mazmanian SK. Disruption of the gut microbiome as a risk factor for microbial infections. Curr. Opin. Microbiol. 2013;16:221-227.
Not in our library10.1016/j.mib.2013.03.009
12.
Fukuda S, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469:543-547.
Not in our library10.1038/nature09646
13.
The human gut microbiome in early-onset type 1 diabetes from the TEDDY study · 2018
No notice
14.
Microbial tryptophan catabolites in health and disease · 2018
No notice
15.
Zelante T, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39:372-385.
Not in our library10.1016/j.immuni.2013.08.003
16.
Cervantes-Barragan, L. et al. Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells. Science10.1126/science.aah5825 (2017).
Not in our library10.1126/science.aah5825
17.
Natividad, J. M. et al. Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome. Cell Metab. 10.1016/j.cmet.2018.07.001 (2018).
Not in our library10.1016/j.cmet.2018.07.001
18.
Dodd D, et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017;551:648-652.
Not in our library10.1038/nature24661
19.
Guo X, et al. Innate lymphoid cells control early colonization resistance against intestinal pathogens through ID2-dependent regulation of the microbiota. Immunity. 2015;42:731-743.
Not in our library10.1016/j.immuni.2015.03.012
20.
Hoyles L, et al. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat. Med. 2018;24:1070-1080.
Not in our library10.1038/s41591-018-0061-3
21.
Krishnan S, et al. Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages. Cell Rep. 2018;23:1099-1111.
Not in our library10.1016/j.celrep.2018.03.109
22.
Madsen AL, Schack-Nielsen L, Larnkjaer A, Mølgaard C, Michaelsen KF. Determinants of blood glucose and insulin in healthy 9-month-old term Danish infants; the SKOT cohort. Diabet. Med. 2010;27:1350-1357.
Not in our library10.1111/j.1464-5491.2010.03134.x
23.
Age-Related Changes in the Composition of Gut Bifidobacterium Species · 2017
No notice
24.
Koga Y, et al. Age-associated effect of kestose on Faecalibacterium prausnitzii and symptoms in the atopic dermatitis infants. Pediatr. Res. 2016;80:844-851.
Not in our library10.1038/pr.2016.167
25.
Li X, Jiang B, Pan B, Mu W, Zhang T. Purification and partial characterization of Lactobacillus species SK007 lactate dehydrogenase (LDH) catalyzing phenylpyruvic acid (PPA) conversion into phenyllactic acid (PLA). J. Agric. Food Chem. 2008;56:2392-2399.
Not in our library10.1021/jf0731503
26.
Koide S, Iwata S, Matsuzawa H, Ohta T. Crystallization of allosteric l-lactate dehydrogenase from Thermus caldophilus and preliminary crystallographic data. J. Biochem. 1991;109:6-7.
Not in our library
27.
Takashi M, So I, Hiroshi S, Haruhiko M, Takahisa O. Sequence and characteristics of the Bifidobacterium longum gene encoding l-lactate dehydrogenase and the primary structure of the enzyme: a new feature of the allosteric site. Gene. 1989;85:161-168.
Not in our library10.1016/0378-1119(89)90476-9
28.
Bottacini F, et al. Global transcriptional landscape and promoter mapping of the gut commensal Bifidobacterium breve UCC2003. BMC Genomics. 2017;18:991.
Not in our library10.1186/s12864-017-4387-x
29.
Hirayama Y, et al. Development of a double-crossover markerless gene deletion system in Bifidobacterium longum: functional analysis of the α-galactosidase gene for raffinose assimilation. Appl. Environ. Microbiol. 2012;78:4984-4994.
Not in our library10.1128/aem.00588-12
30.
Matsumura H, Takeuchi A, Kano Y. Construction of Escherichia coli–Bifidobacterium longum shuttle vector transforming B. longum 105-A and 108-A. Biosci. Biotechnol. Biochem. 1997;61:1211-1212.
Not in our library10.1271/bbb.61.1211
31.
Multivariable association discovery in population-scale meta-omics studies · 2021
No notice
32.
Repeated Measures Correlation · 2017
Corrected
33.
Alfa MJ, et al. An outbreak of necrotizing enterocolitis associated with a novel Clostridium species in a neonatal intensive care unit. Clin. Infect. Dis. 2002;35:S101-S105.
Not in our library10.1086/341929
34.
Butel M-J, et al. Conditions of bifidobacterial colonization in preterm infants: a prospective analysis. J. Pediatr. Gastroenterol. Nutr. 2007;44:577-582.
Not in our library10.1097/mpg.0b013e3180406b20
35.
Bacterial Diversity in Meconium of Preterm Neonates and Evolution of Their Fecal Microbiota during the First Month of Life · 2013
No notice
36.
Arboleya S, et al. Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol. Ecol. 2012;79:763-772.
Not in our library10.1111/j.1574-6941.2011.01261.x
37.
Intestinal microbiota development and gestational age in preterm neonates · 2018
No notice
38.
Metabolites of lactic acid bacteria present in fermented foods are highly potent agonists of human hydroxycarboxylic acid receptor 3 · 2019
Corrected
39.
Ahmed K, et al. Deorphanization of GPR109B as a receptor for the β-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis. J. Biol. Chem. 2009;284:21928-21933.
Not in our library10.1074/jbc.m109.019455
40.
Irukayama-Tomobe Y, et al. Aromatic d-amino acids act as chemoattractant factors for human leukocytes through a G protein-coupled receptor, GPR109B. Proc. Natl Acad. Sci. USA. 2009;106:3930-3934.
Not in our library10.1073/pnas.0811844106

All 111 references

Cited by papers we hold 8

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.